Dr. Matthew James Zirwas, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2359 E Main St, Bexley, OH 43209 Phone: 614-947-1716 Fax: 614-652-3048 |
Susan T Nedorost, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2359 E Main St, Bexley, OH 43209 Phone: 614-947-1716 |
Jaimie Dawn Rodger, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2359 E Main St, Bexley, OH 43209 Phone: 614-947-1716 Fax: 614-947-1743 |
News Archive
A team of researchers from the Johns Hopkins Children's Center, Vanderbilt University and elsewhere have demonstrated that high blood pressure and anemia together put children with sickle cell disease (SCD) at serious danger for symptomless or so-called "silent" strokes, although either condition alone also signaled high risk.
Researchers at Eindhoven University of Technology, together with the Italian company Esaote, have developed a new technique to measure the blood pressure.
Forest Laboratories have announced that Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII), the first and only fixed-dose combination of the opioid oxycodone HCl (5 mg) and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (400 mg), was approved by the U.S. Food and Drug Administration (FDA) for the short-term management of acute, moderate to severe pain.
Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring drug resistance along the Thailand-Cambodia border where patients taking artemisinin combination therapy - the most potent treatment for malaria - have been clearing the parasite from their bodies more slowly.
› Verified 6 days ago